Skip to main content
Corterve
10 Studies Recruiting

Clinical Trials Near Bangalore, India

Find research studies actively recruiting participants near Bangalore. Studies are run at established research institutions including Kidwai Memorial Institute and HCG Cancer Centre.

Top Research Institutions in Bangalore

1

Kidwai Memorial Institute

2

HCG Cancer Centre

3

Narayana Health

Recruiting Studies Near Bangalore

#1

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

RECRUITINGPHASE3Bristol-Myers Squibb

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

📍 Long Beach, California📍 Redlands, California📍 Basalt, Colorado
#2

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

RECRUITINGPHASE3Eli Lilly and Company

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will include participants who are unable or unwilling to use Positive Airway Pressure (PAP) therapy and study YSA2 will include participants who are on PAP therapy for at least 3 months at time of screening and plan to continue PAP therapy during the study. Participants will be assigned to the Intervention-Specific Appendix (ISA) that reflects their current PAP usage. Participation in the study will last about 76 weeks.

📍 Cullman, Alabama📍 Long Beach, California📍 Los Alamitos, California
#3

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RECRUITINGPHASE3Novo Nordisk A/S

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) and excess body weight when compared to placebo. The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have HFpEF or HFmrEF and excess body weight. Participants will get NNC0487-0111 or placebo by injection once a week. Which treatment participants get is decided by chance. NNC0487-0111 is a new medicine that doctors cannot prescribe yet, but it has been tested in people before.

📍 Alexander City, Alabama📍 Fairhope, Alabama📍 Gilbert, Arizona
#4

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

RECRUITINGPHASE3AstraZeneca

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron and dapagliflozin in combination, compared with elecoglipron alone and dapagliflozin alone, in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated with other background glucose-lowering medication.

📍 Kaohsiung City📍 Taichung📍 Weston-super-Mare
#5

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

RECRUITINGPHASE4AstraZeneca

The purpose of this study is to observe the safety and tolerability of Breztri aerosphereTM as maintenance treatment in Indian patients with moderate to severe COPD.

📍 Dalgate, Drugjan📍 Hyderabad📍 Lucknow
#6

A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

RECRUITINGPHASE4Pfizer

This is a multicenter, single-arm, open-label Phase 4 study evaluating the safety and tolerability of rimegepant 75 mg orally disintegrating tablet (ODT) for the acute treatment of migraine (with or without aura) in adult patients in India who have had an insufficient response, intolerance, or contraindication to triptans. It will enroll approximately 60 participants.

📍 Visakhapatnam, Andhra Pradesh📍 Gurugram, Haryana📍 Bangalore, Karnataka
#7

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

RECRUITINGPHASE3Novo Nordisk A/S

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.

📍 San Diego, California📍 Miami, Florida📍 Ocala, Florida
#8

A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF

RECRUITINGPHASE3Pfizer

The purpose of this phase 3 multicenter, double-blinded, placebo-controlled study in India is to learn about the safety and immunogenicity of RSVpreF in adults.

📍 Visakhapatnam, Andhra Pradesh📍 Bangalore, Karnataka📍 Bangalore, Karnataka
#9

Study of Olverembatinib (HQP1351) in Patients With CML-CP

RECRUITINGPHASE3Ascentage Pharma Group Inc.

Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure criteria while receiving bosutinib in Part A may be able to receive olverembatinib in crossover follow-on study.

📍 Birmingham, Alabama📍 Anchorage, Alaska📍 Goodyear, Arizona
#10

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

RECRUITINGPHASE3Novartis Pharmaceuticals

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).

📍 Birmingham, Alabama📍 Anchorage, Alaska📍 Goodyear, Arizona

Clinical Trials in Bangalore: FAQ

How do I find clinical trials near Bangalore?

Corterve aggregates all actively recruiting clinical trials near Bangalore, India from the ClinicalTrials.gov database. Simply browse the listings on this page or take our assessment to find trials that may be relevant.

Does it cost anything to take part in a study?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What research institutions are located in Bangalore?

Bangalore is home to several leading research institutions, including Kidwai Memorial Institute, HCG Cancer Centre, Narayana Health. These facilities run clinical trials across Oncology, Neurology, Cardiology, and other therapeutic areas.

Ready to see studies near you?

Take our assessment to see research studies recruiting near Bangalore that may be relevant. Study teams decide who joins.

See studies near you